Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Commentary
  • Published:

Bringing safe and effective cell therapies to the bedside

New rules to assess the safety and efficacy of human cell- and tissue-based products are the culmination of a multiyear, cooperative effort between the US government and the biotech industry.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

Purchase on Springer Link

Instant access to full article PDF

Prices may be subject to local taxes which are calculated during checkout

References

  1. Department of Health and Human Services, Food and Drug Administration. Human cells, tissues, and cellular and tissue-based; donor screening and testing; and related labeling. Fed. Regist. 70, 29949–29952 (2005). <http://reform.house.gov/UploadedFiles/FDA%20Regulation%2021%20CFR%201271.pdf>

  2. Department of Health and Human Services, Food and Drug Administration. Application of current statutory authorities to human somatic cell therapy products and gene therapy products, Docket 93N-0173. Fed. Regist. 58, 53248–53251 (1993). <http://www.fda.gov/cber/genadmin/fr101493.pdf>

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Preti, R. Bringing safe and effective cell therapies to the bedside. Nat Biotechnol 23, 801–804 (2005). https://doi.org/10.1038/nbt0705-801

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt0705-801

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing